Healthcare New Highs: Nordion Inc(USA) (NYSE:NDZ), WellPoint Inc (NYSE:WLP), RTI Surgical Inc (NASDAQ:RTIX), Novartis AG (ADR) (NYSE:NVS)

Nordion Inc (USA) (NYSE:NDZ) announced that it has entered into an amendment to the previously announced definitive agreement with Sterigenics (the “Arrangement Agreement” and, as amended, the “Amended Arrangement Agreement”) setting out the terms and conditions of the proposed acquisition by Sterigenics of all the issued and outstanding common shares of Nordion. Nordion Inc(USA) (NYSE:NDZ) stock performance was 6.99% in last session and finished the day at $ 12.39. Traded volume was 5,637,059 shares in the last session and the average volume of the stock remained 1,307,940 shares. The beta of the stock remained 0.35.

WellPoint Inc (NYSE:WLP) s stock had its “hold” rating reiterated by analysts at Citigroup Inc. in a research report issued to clients and investors on Thursday, Stock Ratings News reports. They currently have a $101.00 price target on the stock. Citigroup Inc.’s price target points to a potential downside of 1.41% from the stock’s previous close. WellPoint Inc (NYSE:WLP) rose 1.56% percent to $ 102.44 yesterday on volume of 2,551,334 shares. The intra-day range of the stock was $100.00 – 102.72. WellPoint Inc (NYSE:WLP) has a market capitalization of $ 29.97 billion.

RTI Surgical Inc(NASDAQ:RTIX) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research note issued on Tuesday, American Banking & Market News reports. The firm currently has a $4.50 price objective on the stock. RTI Surgical Inc (NASDAQ:RTIX)’s stock on May 5, 2014 reported an increase 3.25% to the closing price of $ 4.77. Its fifty two weeks range is $ 2.77 – 4.87. The total market capitalization recorded $ 269.27 million. The overall volume in the last trading session was 1,576,440 shares. In its share capital, RTI Surgical Inc(NASDAQ:RTIX) has 56.62 million outstanding shares.

Novartis AG (ADR) (NYSE:NVS) last released its earnings data on Thursday, April 24th. The company reported $1.31 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.27 by $0.04. On Friday, shares of Novartis AG (ADR) (NYSE:NVS) advanced/dropped 768% to close the day at $888. Company return on investment (ROI) is 56.677% and its monthly performance is recorded as 60.88%. Novartis AG (ADR) (NYSE:NVS) quarterly revenue growth is 878%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone